Wed.May 22, 2024

article thumbnail

How to take advantage of the connected health opportunity in your next drug launch

Pharmaceutical Technology

When new medicines hit the market, sharing educational content with physicians, pharmacists, and patients is vital for ensuring safe and appropriate use.

Medicine 130
article thumbnail

Scientists Warn Brain Diseases Are Getting Worse as Climate Change Intensifies

AuroBlog - Aurous Healthcare Clinical Trials blog

Climate change is making the symptoms of certain brain conditions worse, our new review has found. Conditions that can worsen as temperature and humidity rise include stroke, migraines, meningitis, epilepsy, multiple sclerosis, schizophrenia, Alzheimer’s disease and Parkinson’s.

Scientist 242
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

No nitrosamines: How parenteral packaging is evolving to meet today’s E&L challenges

Pharmaceutical Technology

As the nitrosamine scandal continues, we explore the advancements in parenteral packaging materials that are reducing the risk of this contaminant in modern injectables.

Packaging 243
article thumbnail

Biogen, looking to diversify, acquires immune drugmaker HI-Bio for $1.15B

Bio Pharma Dive

The deal, only Biogen’s third since the start of 2018, is a sign the company is open to branching out beyond the neurological drugs that have long been its focus.

Drugs 198
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

CDSCO calls for timely reporting of adverse events related to medical devices to MvPI

AuroBlog - Aurous Healthcare Clinical Trials blog

The Central Drugs Standard Control Organisation (CDSCO) has requested stakeholders to take appropriate action for timely reporting of adverse events related to medical devices to the Materiovigilance Programme of India (MvPI), in the backdrop of shifting the segment to licensing regime.

In-Vitro 189
article thumbnail

SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca

Bio Pharma Dive

AstraZeneca has an exclusive chance to buy the startup, which is developing a muscle-protecting weight loss medicine, within the next two years.

Medicine 198

More Trending

article thumbnail

Pfizer expands cost cuts with new $1.5B target

Bio Pharma Dive

The company, which previously announced plans to trim $4 billion in spending by the end of 2024, aims to save another $1.5 billion over the next three years.

179
179
article thumbnail

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Pharmaceutical Technology

Genmab has concluded the acquisition of ProfoundBio, a clinical-stage biotechnology company, in an all-cash transaction valued at $1.8bn.

147
147
article thumbnail

Regeneron faces new biosimilar threats; An AI biotech lays off staff

Bio Pharma Dive

Today’s rundown also includes news of an expanded partnership for Boehringer Ingelheim and updates to emerging medicines from GSK and Bristol Myers.

Medicine 179
article thumbnail

Sanofi enters partnership to enhance drug development using AI

Pharmaceutical Technology

Sanofi has entered a collaboration with Formation Bio and OpenAI aimed at harnessing AI to expedite drug development.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?

Bio Pharma Dive

Direct-to-consumer platforms can offer consumers an online path to sourcing popular medications, but some therapeutic areas may be better suited for the business model.

Marketing 159
article thumbnail

UK lung cancer study demonstrates further evidence on importance of CT screening

Pharma Times

Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually

146
146
article thumbnail

Pharmaceutical clean room manufacturing, flooring and design 

Pharmaceutical Technology

Discover the key factors and latest advancements in pharmaceutical clean room manufacturing, flooring, and design to ensure full regulatory compliance.

article thumbnail

New ‘plug and play’ system to offer novel way of delivering vaccines and treatments

Pharma Times

The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines

Vaccine 144
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Process automation and equipment

Pharmaceutical Technology

Download our list of leading pharmaceutical process automation technologies to make an informed purchasing decision.

130
130
article thumbnail

NICE and the controversy over a ‘clinically distinct disease’ designation

pharmaphorum

The debate rages on as NICE considers a 'clinically distinct disease' classification. Learn how this decision could reshape the STA process and patient treatment options.

117
117
article thumbnail

Evotec shuts down gene therapy business in light of Q1 2024 loss 

Pharmaceutical Technology

Evotec will close an Austrian facility as it shuts down its gene therapy business Evotec GT, a move which will affect 40 employees.

article thumbnail

Tony Blair Institute weighs in on use of NHS patient data

pharmaphorum

A think tank set up by former UK Prime Minister Tony Blair has called for the formation of a public-private trust that could oversee the sharing of anonymised patient data with trusted researchers.

Research 115
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

NICE recommends Rhythm’s Imcivree for rare genetic obesity disorder

Pharmaceutical Technology

Rhythm expects Imcivree will be available on the NHS in England and Wales within the next three months.

Genetics 130
article thumbnail

US senators accuse pharma firms of abusing patent system

pharmaphorum

Lawmakers across the political divide have accused the pharma industry of abusing the patent system to keep the prices of their products as high as possible.

article thumbnail

AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio

Pharmaceutical Technology

AstraZeneca has the option to acquire SixPeaks in the next two years if the latter’s bispecific antibody proves successful.

Antibody 130
article thumbnail

GSK’s twice-yearly asthma drug clears two phase 3 trials

pharmaphorum

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new IL-5 inhibitor depemokimab (formerly GSK3511294) has the potential to become the first ultra-long-acting biologic for severe asthma with a six-monthly dosing schedule.

Trials 111
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Alvotech and Dr Reddy’s partner to commercialise AVT03

Pharmaceutical Technology

Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the commercialisation of AVT03 in the US, Europe and the UK.

130
130
article thumbnail

Click buys Better assets to speed its digital obesity drive

pharmaphorum

Digital health firm Click Therapeutics has bought the assets of Better Therapeutics to speed up development of a prescription digital therapeutic for obesity

article thumbnail

AltruBio secures $225m for immune checkpoint programme development

Pharmaceutical Technology

AltruBio has secured $225m in an oversubscribed Series B financing round to propel the clinical development of its ICE programme.

article thumbnail

Pfizer, busy with $4B savings drive, plots even more cuts out to 2027

Fierce Pharma

Pfizer has made frequent headlines in recent months as it moves forward with a campaign to save $4 billion in annual costs by the end of this year. | Pfizer has made frequent headlines in recent months as it moves forward with a campaign to save $4 billion in annual costs by the end of this year. Now, the company has unveiled another savings drive that will run longer.

109
109
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Pfizer Targets Another $1.5B in Cost Cuts By End of 2027

BioSpace

Amid its ongoing efforts to trim $4 billion in spending in 2024, Pfizer in an SEC filing on Wednesday said it is looking to save an additional $1.5 billion over the next several years.

106
106
article thumbnail

Immune checkpoint enhancer biotech AltruBio raises $225m

pharmaphorum

Immune checkpoint enhancer biotech AltruBio raises $225m to support phase 2 trials of its PSGL-1-targeted drug for ulcerative colitis

Trials 105
article thumbnail

New patent for Ferring Pharms drug NOCDURNA

Drug Patent Watch

Annual Drug Patent Expirations for NOCDURNA Nocdurna is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier.

Drugs 105
article thumbnail

Pharma Pulse 5/22/24: A Pharmacist’s Impact on Inclusive Health Care, ChatGPT Usage to Support Drug Development & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud